John Sourbeer

Stock Analyst at UBS

(0)
# 4655
Out of 5,319 analysts
51
Total ratings
30.77%
Success rate
-22.37%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
CYRX CryoPort
Maintains: Strong Buy
10 11
5.54 98.56% 6 Apr 1, 2025
STVN Stevanato Group
Maintains: Neutral
24 24
21.86 7.5% 2 Mar 7, 2025
QDEL QuidelOrtho
Maintains: Neutral
43 45
25.17 78.78% 3 Feb 13, 2025
QGEN Qiagen
Maintains: Neutral
50 48
40.71 17.91% 4 Feb 7, 2025
WST West Pharmaceutical ...
Upgrades: Buy
350 390
201.9 93.16% 3 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
2
1.17 70.94% 3 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
133 145
71.2 103.65% 3 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
12 15
n/a n/a 2 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
452 480
296.28 62.01% 4 Mar 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 8
1.08 594.44% 2 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
94 102
36.28 181.15% 3 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
58 64
n/a n/a 6 Feb 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 3
n/a n/a 2 Oct 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
50
7.51 565.78% 1 Feb 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
68
n/a n/a 1 Sep 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
270
139.32 93.8% 1 Sep 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
142 128
130.98 -2.28% 2 Jul 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
13 4
n/a n/a 2 Mar 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Feb 22, 2021